Asahi Ka­sei ac­quires Biono­va and its shiny new Cal­i­for­nia site

Just months af­ter it opened a new GMP man­u­fac­tur­ing site, the US-based bio­phar­ma CD­MO Biono­va Sci­en­tif­ic has been ac­quired by Asahi Ka­sei Med­ical.

The com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER